Synonyms:
Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN
UNII: LB090AB8DB

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Leukocyte antigen CD37 inhibitor PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Lymphoma, Large B-Cell, Diffuse 2 D016403 ClinicalTrials
Leukemia, Lymphocytic, Chronic, B-Cell 1 D015451 ClinicalTrials
Lymphoma, Non-Hodgkin 1 D008228 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4594531
FDA SRS LB090AB8DB